Edition:
United Kingdom

Income Statements: Nicox SA (NCOX.PA)

NCOX.PA on Paris Stock Exchange

4.70EUR
12:50pm BST
Change (% chg)

€-0.14 (-2.99%)
Prev Close
€4.84
Open
€4.80
Day's High
€4.80
Day's Low
€4.70
Volume
25,570
Avg. Vol
65,079
52-wk High
€8.99
52-wk Low
€4.36

Interim Income Statement
View: AnnualInterim

In Millions ofEuro
(except for per share items)
2018
2018-12-31

2018-12-31
Period Length
6 Months
Revenue 3.7
Other Revenue, Total --
Total Revenue 3.7
Cost of Revenue, Total --
Gross Profit --
Selling/General/Admin. Expenses, Total 5.4
Research & Development 10.5
Depreciation/Amortization --
Interest Expense, Net - Operating --
Interest/Investment Income - Operating --
Interest Expense(Income) - Net Operating --
Unusual Expense (Income) --
Other Operating Expenses, Total (0.3)
Total Operating Expense 15.7
Operating Income (11.9)
Interest Expense, Net Non-Operating --
Interest/Invest Income - Non-Operating 0.3
Interest Income(Exp), Net Non-Operating --
Gain (Loss) on Sale of Assets --
Other, Net 0.9
Net Income Before Taxes (10.7)
Provision for Income Taxes 0.0
Net Income After Taxes (10.7)
Minority Interest --
Equity In Affiliates --
U.S. GAAP Adjustment --
Net Income Before Extra. Items (10.7)
Accounting Change --
Discontinued Operations 0.0
Extraordinary Item --
Tax on Extraordinary Items --
Net Income (10.7)
Preferred Dividends --
General Partners' Distributions --
Miscellaneous Earnings Adjustment --
Pro Forma Adjustment --
Interest Adjustment - Primary EPS --
Income Available to Com Excl ExtraOrd (10.7)
Income Available to Com Incl ExtraOrd (10.7)
Basic Weighted Average Shares 29.78
Basic EPS Excluding Extraordinary Items (0.361)
Basic EPS Including Extraordinary Items (0.361)
Dilution Adjustment --
Diluted Weighted Average Shares 29.78
Diluted EPS Excluding ExtraOrd Items (0.361)
Diluted EPS Including ExtraOrd Items (0.361)
DPS - Common Stock Primary Issue 0.000
Gross Dividends - Common Stock 0.0
Total Special Items --
Normalized Income Before Taxes (10.7)
Effect of Special Items on Income Taxes --
Inc Tax Ex Impact of Sp Items 0.0
Normalized Income After Taxes (10.7)
Normalized Inc. Avail to Com. (10.7)
Basic Normalized EPS (0.361)
Diluted Normalized EPS (0.361)

Nicox teams up with Chinese firm to develop and sell glaucoma drug

PARIS French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive licence agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.